| abstract |
This invention relates to the use of a compound or its pharmaceutically acceptable salt, solvate or hydrate, where the compound has the structure: where * denotes the chiral center of (R) - or (S) -configuration, and the formula includes racemic and other mixtures of molecules in (R) - or (S) -configuration, wherein said compound is used for the preparation of a medicinal product intended for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CCI), multifocal motor neuropathy with a conduction block (M H) or paraproteinemic demyelinating peripheral neuropathy (PDN). Also, the invention relates to the use of a compound or a pharmaceutically acceptable salt, solvate or hydrate thereof, where the compound has the structure: wherein said compound is used for the preparation of a medicament intended for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIHV), multifocal motor neuropathy with a conduction block MDN) or paraproteinemic demyelinating peripheral neuropathy (PDN). |